Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.

Cancer immunology, immunotherapy : CII - 1 Nov 1994

Vollenweider I, Moser R, Groscurth P

Abstract excerpt

A series of 62 lymphokine-activated killer cell (LAK) cultures from 44 different donors was investigated for the distribution of various CD markers during a cultivation period of 3 weeks. Great differences in the phenotypic pattern were found between different donors, but similar changes of the subset pattern of various donors allowed a classification of the LAK cultures into four distinct LAK types. LAK type 1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Cells, Cultured
Share to Cytokines

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interleukin-2

Share to Membrane Glycoproteins

Share to Phenotype

Share to Transcription, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 7987862
DOI: 10.1007/BF01519983
PMCID: PMC11038294

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.PMID 7987862Read ↗

High release of tumor necrosis factor alpha, interferon gamma and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cells.Semantic proximity Read ↗

Generation of lymphokine-activated killer cells by adherent LGL phenotype cells and non-adherent T lymphocytes.Semantic proximity Read ↗

Human spleen and peripheral blood lymphocytes activated by interleukin-2 have similar phenotypic and functional characteristics.Semantic proximity Read ↗

Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and LifespanSemantic proximity Read ↗

Recurrent Stimulation of NK Cell Clones with K562 Expressing Membrane-Bound IL-21 Affects Their Phenotype, IFN-γ Production and LifespanSemantic proximity Read ↗

Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.Semantic proximity Read ↗

Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.Semantic proximity Read ↗

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.Semantic proximity Read ↗

Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of “senescent” NK cells to lose CD57 expression and start expressing NKG2ASemantic proximity Read ↗

Natural killer activity of human liver-derived lymphocytes in various liver diseases.Semantic proximity Read ↗

Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes.Semantic proximity Read ↗

Definition of early progenitors and functional maturation of human natural killer cells: requirements for cytocidal activity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.